Roberto Borea: Utilizing ctDNA in mechanisms of resistance to targeted therapies in patients with metastatic NSCLC

Roberto Borea, PhD student at The University of Genoa, shared a paper Sophie M. Ernst and colleagues authored on X:

“Out in Nature Reviews Clinical Oncology:

– ctDNA helps uncover resistance mechanisms to targeted therapies
– Standardized protocols are crucial for improving applications
– ctDNA + tissue provides a more comprehensive view.”